NCT05266365

Brief Summary

This randomized controlled trial aims to investigate the efficacy of the video-based exercise programs in patients with degenerative meniscus tears.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
81

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 28, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 4, 2022

Completed
28 days until next milestone

Study Start

First participant enrolled

April 1, 2022

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 5, 2026

Completed
Last Updated

November 21, 2025

Status Verified

November 1, 2025

Enrollment Period

3 years

First QC Date

February 28, 2022

Last Update Submit

November 18, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Knee Injury and Osteoarthritis Outcome Score (KOOS)

    Short-term and long-term symptoms and function will be assessed with the Knee injury and Osteoarthritis Outcome Score (KOOS) that is developed as an extension of the WOMAC Osteoarthritis Index. The score is a percentage score from 0 to 100, 0 representing extreme problems and 100 representing no problems.

    Baseline

Secondary Outcomes (9)

  • Knee Injury and Osteoarthritis Outcome Score (KOOS)

    At the end of 8-week intervention

  • Visual Analogue Scale (VAS)

    Baseline

  • Visual Analogue Scale (VAS)

    After 8-week intervention

  • Active Range of Motion

    Baseline

  • Active Range of Motion

    At the end of 8-week intervention

  • +4 more secondary outcomes

Other Outcomes (2)

  • Global Rating of Change

    At the end of 8-week intervention

  • Adherence to Exercise Programs

    Throughout the 8-week intervention period

Study Arms (3)

The Video-based exercise (VBE) group

EXPERIMENTAL

Each subject in the video-based exercise group (only video-based intervention) will receive a treatment protocol consisting of stretching, strengthening, and functional exercises for the knee and hip.

Other: The video-based exercise (VBE)

The standard exercise (SE) group

ACTIVE COMPARATOR

Each subject in the standard exercise group (only clinic-based intervention) will receive a treatment protocol consisting of stretching, strengthening, and functional exercises for the knee and hip.

Other: The standard exercise (SE)

The hybrid exercise (HE) group

EXPERIMENTAL

Each subject in the hybrid exercise group (video-based and clinical-based interventions) will receive a treatment protocol consisting of stretching, strengthening, and functional exercises for the knee and hip.

Other: The hybrid exercise (HE)

Interventions

An 8-week exercise program will be implemented as part of the conservative treatment for degenerative meniscal tears. The physiotherapist will prepare an instructional video that provides a detailed explanation and demonstration of each exercise. Patients will watch this video at home and perform the exercises according to the video instructions.

The Video-based exercise (VBE) group

An 8-week exercise program used in conservative treatment of degenerative meniscus tears will be performed. An exercise program will be performed at the clinic.

The standard exercise (SE) group

An 8-week exercise program will be implemented as part of the conservative treatment for degenerative meniscal tears using a hybrid telerehabilitation model. For the home-based component, the physiotherapist will prepare an instructional video that includes a detailed description and demonstration of each exercise. Patients will watch this video at home and perform the prescribed exercises by following the instructions provided in the video. In addition to the home program, patients will also participate in supervised exercise sessions conducted in the clinical setting.

The hybrid exercise (HE) group

Eligibility Criteria

Age40 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being aged between 40 and 65 years
  • Having the degenerative meniscus tear in at least one knee
  • Having body mass index in the range of 18-30 kg/m2
  • Feeling the pain that lasts for at least 2 months
  • Having grade 1 or grade 2 degenerative meniscal tear diagnosed by an orthopedic specialist according to the MRI results
  • Having the activity level is between 1 and 5 according to the Tegner Activity Scale
  • Having access to the internet via a computer or smartphone
  • Having the ability to read and write Turkish

You may not qualify if:

  • Having undergone arthroscopic partial meniscectomy surgery due to degenerative meniscal tear
  • Participating in a physiotherapy program for degenerative meniscal tear in the last 12 weeks
  • Have received steroid injections in the last 6 months
  • Accompanying conditions such as injury to the surrounding ligaments, congenital anomaly in the affected knee, coxarthrosis and spinal stenosis
  • Presence of any systemic disorder that may affect assessment parameters
  • Failure to cooperate with assessments
  • Any vision or hearing problem that would prevent them from adapting to the assessment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University-Cerrahpasa

Istanbul, Bakırkoy, 34147, Turkey (Türkiye)

Location

Study Officials

  • Tansu Birinci, PhD, PT

    Istanbul University - Cerrahpasa

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 28, 2022

First Posted

March 4, 2022

Study Start

April 1, 2022

Primary Completion

April 1, 2025

Study Completion

January 5, 2026

Last Updated

November 21, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations